No cure available, yet
There is no preventive or curative treatment available for dengue. However, there are a few promising drugs in the trial stage. France-based non-profit International Centre for Genetic Engineering and Biotechnology has developed a vaccine which they hope to launch in a few years. The vaccine has been developed at the Delhi branch of the non-profit. Serum Institute, a Pune-based pharma company, too has reported to have developed a drug (monoclonal anti-body) to treat all four strains of the dengue virus. The company says this would be an injectbile drug costing 5,00010,000 for a single dose. Only one dose will be required. Current dengue treatments are purely on the basis of symptoms, says Yash Javeri, director of Apex Healthcare Consortium, Delhi. He has started using a drug called ulinastatin to treat severe cases of dengue. Ulinastatin prevents organ dysfunction and promotes homeostasis. It is used to treat a disease called sepsis, whose symptoms are similar to dengue's. But its efficacy in treating dengue is yet to be proved. It is being used by many doctors in private hospitals but not in government hospital, says Kavita Khanna, director of Bharat Serums and Vaccine Limited, one of the two companies producing the drug in India. The other company is Lupin, which imports the drug from China.